Diabetes Drugs Could Help Ward Off Dementia, New Study Suggests
- The medicines were associated with reduction in dementia risk
- Researchers call for clinical trials to test the theory
Scientists found there was a 35% reduced risk of dementia associated with sodium glucose cotransporter 2 inhibitors.
Photographer: Andrew Brookes/Image Source/Getty Images
Certain types of medicines used to treat type 2 diabetes might help to prevent some cases of dementia, according to new research that builds on previous evidence suggesting these drugs might be useful in countering debilitating diseases associated with memory loss and cognition.
Scientists found there was a 35% reduced risk of dementia associated with a class of drugs that includes AstraZeneca Plc’s Forxiga and Boehringer Ingelheim GmbH’s Jardiance, which are called sodium glucose cotransporter 2 inhibitors. They were compared with so-called dipeptidyl peptidase-4 inhibitors, a category that includes Novartis’s Galvus and Johnson & Johnson’s Invokana.